CaBP5 activators are a specialized group of chemicals that enhance the function of the calcium-binding protein 5 (CaBP5), which is a member of the neuronal calcium sensor family of proteins. CaBP5 is known to be involved in the regulation of intracellular calcium signaling pathways, which are crucial for various cellular processes including neurotransmitter release, gene expression, and synaptic plasticity.
The activation of CaBP5 by these chemicals can occur through direct or indirect pathways. Direct activators may bind to the CaBP5 protein, stabilizing its conformation in such a way that it can more effectively bind calcium ions. This direct binding can change the protein's tertiary structure, thereby increasing its affinity for calcium ions or its interaction with target proteins involved in calcium signaling cascades. These interactions can modulate the activity of ion channels or enzymes that are critical for maintaining cellular calcium homeostasis. Indirect activators might work by altering the local intracellular concentration of calcium, thereby influencing the binding of calcium to CaBP5. These chemicals can also affect the synthesis, degradation, or post-translational modifications of CaBP5, leading to an increased level of functional protein available within the cell. Additionally, they may influence the expression of genes encoding CaBP5 or related regulatory proteins, thereby modulating the overall calcium signaling pathway.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
This L-type calcium channel activator can potentially influence CaBP5 by enhancing calcium influx. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176 can increase calcium entry through L-type calcium channels, potentially influencing CaBP5. | ||||||
CGP 37157 | 75450-34-9 | sc-202097 sc-202097A | 5 mg 25 mg | $115.00 $463.00 | 3 | |
This mitochondrial Na+/Ca2+ exchanger inhibitor can influence calcium signaling, potentially affecting CaBP5. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is an L-type calcium channel blocker that can potentially influence CaBP5 by modulating calcium influx. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine modulates ryanodine receptors involved in calcium release from the sarcoplasmic reticulum, potentially influencing CaBP5. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene inhibits ryanodine receptors, potentially influencing CaBP5 through altered calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco-/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially influencing CaBP5 by altering calcium homeostasis. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB is a modulator of IP3 receptors, potentially influencing CaBP5 through altered calcium signaling. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
Xestospongin C is an IP3 receptor inhibitor, potentially influencing CaBP5 through altered calcium signaling. | ||||||
TMB-8 • HCl | 53464-72-5 | sc-3522 sc-3522A | 10 mg 50 mg | $43.00 $129.00 | 10 | |
TMB-8 inhibits IP3-mediated calcium release, potentially influencing CaBP5. | ||||||